What Vidisic Treats: Main Uses and Benefits

Carbomer gels are used for the symptomatic treatment of dry eye syndrome. This treatment is generally used for managing conditions characterized by periods of heightened symptoms associated with tear deficiency, where supportive lubrication is needed.

Vidisic is commonly used across conditions presenting with recurrent or episodic manifestations of dry eye. The gel provides support that helps ease the overall symptom burden in situations involving persistent discomfort. The therapy helps address symptom clusters related to physical discomfort and inflammatory or irritative states on the ocular surface, such as burning, soreness, and the gritty feeling.

The product is used within therapeutic domains where additional symptomatic support is needed, which contributes to improved comfort during periods when these symptoms interfere with daily functioning.

It supports the patient during difficult episodes by easing distress for adults and older adults whose symptoms may intensify due to specific real-world stressors, including prolonged screen use or dry air exposure.

Who Can and Cannot Use Vidisic?

Vidisic eligibility is defined by regulatory bodies across specific population groups and clinical conditions, detailing who is permitted to use the medicine and who is officially restricted.

Contraindications (Must Not Use)

Use of Vidisic is strictly contraindicated for individuals with known hypersensitivity to the active ingredient, Carbomer, or to any of the product's excipients. Additionally, the medicine must not be used by patients who present with undiagnosed conjunctivitis or other specific ocular infections.

Age-Group Eligibility and Data Status

Conditional Use and Special Populations

Safety has not been established for Vidisic during pregnancy or lactation. Use in these physiological states is therefore restricted and contingent upon a physician's benefit/risk assessment. The label also specifies that soft contact lens wearers must remove their lenses before applying the gel and wait at least 15 minutes before reinsertion. No specific eligibility restrictions are noted for patients with hepatic or renal impairment.

Interactions with other medicines and products

Vidisic (Carbomer ophthalmic gel) is a highly viscous, topical ocular preparation that exhibits a limited interaction profile, which is primarily procedural and not systemic. Due to its intended use as a surface lubricant with negligible systemic absorption, the risk of traditional drug-drug interactions involving metabolic enzymes (such as CYP450) or drug transporters is considered absent and is not documented in regulatory prescribing information.

Administration Timing Rules

The most significant interaction pattern is a physical interference requiring strict separation of administration with other topically applied ocular medicines (e.g., eye drops or eye ointments). This rule is in place to prevent the viscous gel from creating a physical barrier that could impede the proper contact and subsequent effectiveness of the co-administered product.

Systemic and Substance Interactions

Regulatory documentation confirms that there are no documented systemic interactions with orally or parenterally administered medicines. Furthermore, the official labeling does not describe any specific interactions or restrictions related to the consumption of food, alcohol, dietary supplements, or herbal products when using Vidisic gel.

Vidisic's core mechanism is physico-chemical and non-pharmacological, defined by the mucoadhesion of the Carbomer polymer to the mucin layer of the corneal and conjunctival epithelium. The polymer's carboxylic groups form hydrogen bonds with the mucin glycoproteins on the eye's surface, creating a cohesive film. This adherence physically anchors the substance and resists mechanical displacement, contributing to sustained surface coverage. The gel matrix significantly increases the overall viscosity of the fluid layer, directly impacting tear film dynamics. This biophysical effect results in a prolonged precorneal residence time by slowing down the natural processes of tear drainage and mechanical clearance. This sustained retention contributes to the establishment of a stable, humid microenvironment, thereby reducing friction and limiting water loss from the epithelial cells. The highly hydrophilic nature of the polymer allows it to function as a durable water reservoir, creating a persistent physical barrier that resists the rate of evaporation. This structural maintenance of the fluid layer influences the physiological equilibrium of the superficial ocular tissues.

Vidisic is a sterile eye gel containing the lubricant carbomer and is used as an artificial tear to relieve symptoms of dry eye.

Administration and Dosage

• Recommended Dose: The usual dose is to instill one drop into the conjunctival sac (the corner of the eye nearest the nose) 3 to 5 times each day or as needed for lubrication. It is often recommended to use a drop before retiring for the night.
• Application Technique: To apply, first wash your hands thoroughly. Gently pull your lower eyelid down to form a small pocket. Hold the tube vertically with the nozzle tip above the eye, then squeeze gently to dispense one drop into the pocket. Do not allow the nozzle tip to touch the eye or any other surface, as this can contaminate the gel. After application, release the lower eyelid and blink a few times to spread the gel over the entire surface of the eye.

Important Considerations

• Contact Lenses: If you wear soft contact lenses, they must be removed before applying Vidisic. Wait for at least 15 minutes after using the gel before reinserting your lenses.
• Other Eye Medications: If you are using other eye drops or ointments, Vidisic should generally be administered last, allowing a gap of approximately 15 minutes between the application of the other medication and the gel.
• Blurred Vision: A temporary blurring of vision may occur immediately following instillation due to the gel's viscosity. Exercise caution when driving or operating machinery until clear vision is restored.
• Shelf Life: The contents of the tube must be discarded one month after first opening to maintain sterility.

Research Evidence / Overview of Studies for Vidisic (Carbomer Gel)

Evidence for Symptomatic Relief of Dry Eye Syndrome

The research exploring the use of Carbomer gel, the active component in Vidisic, for symptomatic dry eye relief primarily consists of short-term clinical trials and systematic reviews. These studies have been used in research exploring symptoms associated with tear film deficiency and discomfort. Researchers was studied for dry eye syndrome in adults and older adults and applied in studies examining patient-reported experiences of discomfort.

The trials generally research monitored patient-reported outcomes describing perceived discomfort, such as the gritty feeling, burning, and irritation often associated with dry eye. They also research examined physical, objective measures. For instance, the Tear Film Break-up Time (TBUT) was frequently measured, which assesses the stability of the tear film layer on the eye surface. Research monitored measured outcomes related to the stability of the tear film and how patients reported their symptoms. Studies reported patterns in TBUT measurements after gel application. This observed pattern reflects the gel's highly viscous composition.

Comparative Research and Measured Outcomes

Research has explored how Carbomer gel performs when compared with a placebo (inactive substance) or with other standard artificial tear substitutes. The studies are relevant in trials assessing short-term or episodic symptom patterns and often focused on outcomes related to physical discomfort. Specifically, the research was observed in studies examining the condition of the eye's surface using specific dyes to see if any epithelial damage or drying was present (ocular surface staining).

Comparative evidence includes studies using diverse formulations, which is a factor in interpreting the evidence. Research examined different concentrations of Carbomer, as well as formulations with and without common preservatives. Therefore, findings were mixed when comparing the gel to all other types of artificial tears, which is a common pattern in this category of products.

Research Gaps and Unanswered Questions

The majority of controlled trials supporting the initial evidence for Carbomer gel was observed in short-term research scenarios. This means that follow-up durations were limited in many of the core clinical trials. Long-term outcomes related to the use of the gel for dry eye are not fully characterized. Dedicated clinical trial data specifically supporting the use of Carbomer gel in children or adolescents have not been consistently published. Scientific certainty in this population remains low.

Key Studies & References

1. Vidisic® 0.2% w/w Eye Gel (Carbomer) Patient Information Leaflet (Source for study populations, non-clinical data gaps, and general characteristics)

Common questions about Vidisic (FAQ)

Q: Is Vidisic generally available over-the-counter or only by prescription?

A: According to regulatory labeling in many regions, Vidisic is often classified as a Pharmacy-only or Over-the-Counter (OTC) medicine. This status typically means it can be purchased without the need for a doctor's prescription, though it is usually supplied only through a pharmacist.

Q: Is there a recommended waiting period before driving after using Vidisic?

A: Official product information states that Vidisic gel can cause temporary blurring of vision immediately after application. Because of this, no specific waiting time is set. Caution should be exercised, and driving or operating machinery is to be avoided until clear vision is restored.

Q: Can Vidisic be used long-term for chronic dry eyes?

A: Vidisic contains a preservative, which official product information indicates may cause eye irritation, especially when used frequently or for a long period of time. Official regulatory guidance often notes that preservative-free products are preferred for long-term treatment of chronic dry eye conditions.

Q: Can Vidisic be used by people with sensitive eyes?

A: Official product warnings note that the preservative found in some Vidisic formulations may cause ocular irritation, especially with frequent use. Regulatory guidance has noted the preference for preservative-free products for long-term chronic treatment.

Q: Why is Vidisic often recommended for use at nighttime?

A: Vidisic is typically included in dosing recommendations for use before retiring for the night. This is related to the gel's specific structure, which has a high water-binding capability. The gel forms a stable film on the eye's surface that adheres to provide sustained lubrication.

Q: Is the sensation of a film over the eye a normal effect of Vidisic?

A: Yes, the sensation of a film is related to the product’s intended function. The gel's mechanism involves forming a stable hydrophilic film that is designed to adhere to the eye's surface. The physical effect of this cohesive film is an expected outcome of the gel providing sustained lubrication.

Q: Why does Vidisic sometimes cause a sticky feeling on the eyelashes or eyelids?

A: The sensation of stickiness or eyelid crusting is listed in official documents as a potential undesirable effect. This effect is related to the gel’s physical properties, specifically its thick, viscous structure and its ability to adhere closely to the eye surface to deliver sustained moisture.

Q: Is Vidisic effective for treating dry eye caused by computer use?

A: Vidisic is officially indicated for the symptomatic relief of dry eyes associated with conditions like the sicca syndrome. The regulatory purpose of the gel is to relieve symptoms like dryness and irritation, and its function as a lubricant is not dependent on the specific cause of the dry eye (such as computer use).

Q: Is Vidisic similar to eye drops used for red eyes or allergies?

A: Vidisic is classified as a lacrimal fluid substitute, meaning it functions as an ocular lubricant to replace or stabilize the natural tear film. This mechanism is different from eye drops used to treat redness (vasoconstrictors) or eye drops used for allergic conditions (antihistamines).

Q: Is there any risk of developing an allergy to Vidisic after prolonged use?

A: Official documents state that Vidisic is contraindicated (must not be used) in the presence of a known hypersensitivity (allergy) to the active ingredient, Carbomer, or any other component. While rare, intolerance reactions to the ingredients have been seen in isolated cases.

Q: What happens if Vidisic gets into the nose or mouth?

A: Regulatory studies show that the systemic absorption of Vidisic (the amount that enters the bloodstream) is considered negligible when administered to the eye. Most of the active ingredient, Carbomer, is eliminated from the body unchanged, which addresses the primary concern about toxicity.

How to Store and Dispose of Vidisic Eye Gel

The storage and disposal of Vidisic Eye Gel are governed by official regulatory instructions focused on maintaining the product's stability and sterility.

Storage Requirements

Stability and Disposal Rules

Once a tube of Vidisic is opened, the contents must be discarded after one month (28 days), regardless of remaining gel.

Expired or unused Vidisic must not be disposed of in household waste or flushed down the toilet. Official instructions require consulting a pharmacist for guidance on proper pharmaceutical waste disposal.